| Marc S Schultz, MD | |
|
1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 | |
| (626) 851-1011 | |
| Not Available |
| Full Name | Marc S Schultz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 1011 Baldwin Park Blvd, Baldwin Park, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871641654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | G75846 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Baldwin Park | Baldwin park, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital (Canada), European Molecular Biology Laboratory (Germany), and Massachusetts Institute of Technology (USA) have created a new computational method called NetworKIN.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital (Canada), European Molecular Biology Laboratory (Germany), and Massachusetts Institute of Technology (USA) have created a new computational method called NetworKIN.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc S Schultz, MD 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 | Marc S Schultz, MD 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 |
News Archive
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital (Canada), European Molecular Biology Laboratory (Germany), and Massachusetts Institute of Technology (USA) have created a new computational method called NetworKIN.
Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, has received a $2.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health for research to combat the nation's No. 1 killer — heart disease.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
› Verified 2 days ago
Arjang Kasravi, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 800-780-1277 | |
Dr. Jennifer Jang, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-813-4725 Fax: 626-813-4684 | |
Rody A. Yoshinaka, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Carolyn Anne Hardy, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Dennis Matejka, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Dr. Jayon Kim, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Previn J De Silva, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 |